Clinical trials
Phase 3 Atherosclerosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| GlaxoSmithKline | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Esperion Therapeutics, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Calgary | 2 |
| Anand, Sonia, M.D. | 1 |
| AtheroGenics | 1 |
| Axio Research. LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 32 |
| Cardiovascular Diseases | 13 |
| Diabetes Mellitus | 6 |
| Coronary Disease | 5 |
| Heart Diseases | 5 |
| Hypercholesterolemia | 5 |
| Hyperlipidemias | 4 |
| Coronary Artery Disease | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Hypertension | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.